XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Total Stockholders' Equity - Dolby Laboratories, Inc.
Controlling Interest
Class A Common Stock [Member]
Common Stock
Class A Common Stock [Member]
Additional Paid-In Capital
Beginning balance (in shares) at Sep. 25, 2020   99,000              
Beginning balance at Sep. 25, 2020 $ 2,438,405   $ 0 $ 2,443,138 $ (10,594) $ 2,432,643 $ 5,762    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 142,690     135,198   135,198 7,492    
Other comprehensive loss, net of tax 10,149       9,986 9,986 163    
Distributions to controlling interest (7,362)           7,362    
Stock-based compensation expense 26,313   26,313     26,313      
Shares repurchased (in shares)   0              
Repurchase of common stock (39,985)   (49,550) 9,565   (39,985)      
Cash dividends declared and paid on common stock (22,231)     (22,231)   (22,231)      
Common stock issued under employee stock plans (in shares)               2,000  
Common stock issued under employee stock plans 51,323   51,321     51,323      
Tax withholdings on vesting of restricted stock (in shares)               (1,000)  
Tax withholdings on vesting of restricted stock (28,085)         (28,085) 0   $ (28,084)
Ending balance (in shares) at Dec. 25, 2020   100,000              
Ending balance at Dec. 25, 2020 2,571,217   0 2,565,670 (608) 2,565,162 6,055    
Beginning balance (in shares) at Sep. 24, 2021   100,000              
Beginning balance at Sep. 24, 2021 2,604,232   0 2,607,909 (10,030) 2,597,979 6,253    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 80,010     80,014   80,014 (4)    
Other comprehensive loss, net of tax (1,538)       (1,491) (1,491) (47)    
Distributions to controlling interest (1,435)           (1,435)    
Stock-based compensation expense $ 32,656   32,656     32,656      
Shares repurchased (in shares) (408,508) 0              
Repurchase of common stock $ (35,573)   (22,108) (13,465)   (35,573)      
Cash dividends declared and paid on common stock (25,283)     (25,283)   (25,283)      
Common stock issued under employee stock plans 21,372 $ 0 21,372     21,372      
Tax withholdings on vesting of restricted stock (in shares)               0  
Tax withholdings on vesting of restricted stock (31,920)       0 (31,920) 0   $ (31,920)
Ending balance (in shares) at Dec. 31, 2021   100,000              
Ending balance at Dec. 31, 2021 $ 2,642,521   $ 0 $ 2,649,175 $ (11,521) $ 2,637,754 $ 4,767